Literature DB >> 3498445

Effect of UVB radiation on the biosynthesis of HLA-DR antigens.

W Aberer, H Leibl.   

Abstract

HLA-DR molecules on the surface of immunocompetent cells are thought to represent target structures for the immunomodulating effects of UV radiation during the induction of an immune response. We therefore investigated the effect of UVB radiation on the de novo synthesis of HLA-DR-gamma-chains in the cytoplasm and the expression of alpha- and beta-chains on the surface of the human lymphoblastoid B-cell line Raji. Raji cells were UVB irradiated before biochemical experiments were performed. Cells were then metabolically labeled or radioiodinated and detergent lysates immunoprecipitated using antibodies directed against the gamma- or the alpha- and beta-chain of the HLA-DR molecule. Over a wide dose range, UVB-irradiated Raji cells were shown to still express HLA-DR determinants on their surface and, even more importantly, to be capable of synthesizing HLA-DR-alpha, beta- and gamma-chains in a normal fashion. Despite this, the functional capacity of Raji cells was impaired in a dose-dependent manner. UV radiation thus seems to exert its immunomodulating effects primarily at a different level than the incriminated immune-response-associated antigens, which are expressed as recognition structures on the surface of immunocompetent cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498445     DOI: 10.1007/BF00431225

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  33 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  The effects of ultraviolet light and certain drugs on La-bearing Langerhans cells in murine epidermis.

Authors:  J J Nordlund; A E Ackles; A B Lerner
Journal:  Cell Immunol       Date:  1981-05-01       Impact factor: 4.868

3.  Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light.

Authors:  G Stingl; L A Gazze-Stingl; W Aberer; K Wolff
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Modification of immunological potential by ultraviolet radiation. II. Generation of suppressor cells in short-term UV-irradiated mice.

Authors:  C W Spellman; R A Daynes
Journal:  Transplantation       Date:  1977-08       Impact factor: 4.939

5.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).

Authors:  D N Sauder; F P Noonan; E C DeFabo; S I Katz
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

7.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

8.  The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization.

Authors:  E Sung; P P Jones
Journal:  Mol Immunol       Date:  1981-10       Impact factor: 4.407

9.  Human skin cells synthesize HLA-DR molecules of the same charge and molecular weight as those synthesized by autologous lymphocytes.

Authors:  V B Morhenn; D J Charron; E G Engleman
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

10.  Ultraviolet light depletes surface markers of Langerhans cells.

Authors:  W Aberer; G Schuler; G Stingl; H Hönigsmann; K Wolff
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551

View more
  1 in total

1.  Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation.

Authors:  L A Applegate; R D Ley; J Alcalay; M L Kripke
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.